The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer (cancer pathology markers) as well as those that are used in asking a broader series of questions about the aetiology, subclassification and pathogenesis of cancer (cancer molecular markers).
Cancer molecular markers are those that are used by investigators in research laboratories who are studying novel biomarkers for genomic subclassification of cancers, or identifying new markers to assist in diagnosis, prognosis or monitoring for the recurrence of tumours. The molecular markers also include those that are useful for studying mutation or translocations, cellular proliferation, the immune response to the tumour, apoptosis or angiogenesis.
This broad class of markers assists scientists who are investigating the aetiology and pathogenesis of cancer.
Phone: 02 9698 2022
Lumiprobe DusQ fluorescence quenchers
Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...
Enzo Life Sciences SCREEN-WELL Epigenetics library
Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...
GeneTex G protein-coupled receptor (GPCR) antibodies
GeneTex's goal is to produce the most extensive line of antibodies for human G...
